What role does AllergieCheck | IgE-Antikörper Test play in longevity?

The AllergieCheck (IgE antibody test) measures specific IgE antibodies against allergens. Its direct role in longevity is limited, as it primarily serves allergy diagnostics. However, chronic allergic inflammation—such as from untreated hay fever or asthma—can promote oxidative stress and immune dysregulation, which are linked to accelerated aging. By identifying triggers and enabling avoidance or immunotherapy, the test may indirectly reduce chronic inflammatory load, a factor considered relevant in longevity research. The evidence is mechanistic and not supported by direct longevity studies. The test does not assess biological age or systemic inflammation markers like hs-CRP. Additionally, elevated IgE can occur in parasitic infections or rare immune disorders. For a comprehensive longevity strategy, additional biomarkers (e.g., inflammatory, metabolic parameters) and medical interpretation are necessary. The test is a useful diagnostic tool but not a direct longevity intervention.